文献速递血栓与止血

重症监护患者血小板减少症的处理方法

How do we approach thrombocytopenia in critically ill patients?
PubMed 文献 · Br J Haematol · 2016-12-16

本文综述了重症监护治疗病房(ITU)患者血小板减少症的发生率、机制、预后意义及对器官功能的影响。经典观点认为与凝血酶介导的血小板活化消耗相关,新近描述机制包括血小板黏附于内皮细胞和白细胞、血管性血友病因子释放增加致血小板聚集、红细胞损伤与组蛋白释放、补体系统致血小板破坏。严重血小板减少伴活动性出血或侵入性操作时行血小板输注,预防性输注风险获益不确定。作者基于经验提出实用处理路径。

要点

  • 重症监护患者血小板减少常为多因素,纠正单一病因未必使血小板计数正常化。
  • 严重血小板减少(血小板计数<20×10^9/L)可伴出血,中度减少亦与器官衰竭和不良预后相关。
  • 活动性出血或侵入性操作时输注血小板,预防性输注风险获益不确定。

核心结论

  • 重症监护患者血小板减少常为多因素所致,纠正单一病因未必使血小板计数正常化。
  • 严重血小板减少伴活动性出血或侵入性操作时行血小板输注,但预防性血小板输注的风险获益不确定。
  • 作者基于自身经验描述了指导重症患者血小板减少处理的实用路径。

研究设计与样本

  • 综述,讨论重症监护治疗病房(ITU)患者血小板减少症的发生率、机制、预后意义及对器官功能的影响。

主要发现

  • 严重血小板减少(血小板计数<20×10^9/L)可伴出血,中度血小板减少亦与器官衰竭和不良预后相关。
  • 经典观点认为血小板减少与凝血酶介导的血小板活化消耗相关。
  • 新近描述的机制包括血小板黏附于内皮细胞和白细胞、血管性血友病因子释放增加致血小板聚集、红细胞损伤与组蛋白释放、补体系统致血小板破坏。

临床怎么用

  • 严重血小板减少伴活动性出血或侵入性操作时行血小板输注。
  • 预防性血小板输注在该场景下的风险获益不确定。
  • 作者基于自身经验描述了指导重症患者血小板减少处理的实用路径。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A low platelet count is a frequently encountered haematological abnormality in patients treated in intensive treatment units (ITUs). Although severe thrombocytopenia (platelet count <20 × 109 /l) can be associated with bleeding, even moderate-degree thrombocytopenia is associated with organ failure and adverse prognosis. The aetiology for thrombocytopenia in ITU is often multifactorial and correcting one aetiology may not normalise the low platelet count. The classical view for thrombocytopenia in this setting is consumption associated with thrombin-mediated platelet activation, but other concepts, including platelet adhesion to endothelial cells and leucocytes, platelet aggregation by increased von Willebrand factor release, red cell damage and histone release, and platelet destruction by the complement system, have recently been described. The management of severe thrombocytopenia is platelet transfusion in the presence of active bleeding or invasive procedure, but the risk-benefit of prophylactic platelet transfusions in this setting is uncertain. In this review, the incidence and mechanisms of thrombocytopenia in patients with ITU, its prognostic significance and the impact on organ function is discussed. A practical approach based on the authors' experience is described to guide management of a critically ill patient who develops thrombocytopenia.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Thachil J, Warkentin TE. How do we approach thrombocytopenia in critically ill patients? Br J Haematol. 2016. PMID: 27982413. doi:10.1111/bjh.14482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。